Challenges in Dengue Vaccines Development: Pre-existing Infections and Cross-Reactivity

por Izmirly, Abdullah M., Alturki, Sana O., Alturki, Sawsan O., Connors, Jennifer, Haddad, Elias K.
Publicado 2020

The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development

por Alturki, Sana O., Alturki, Sawsan O., Connors, Jennifer, Cusimano, Gina, Kutzler, Michele A., Izmirly, Abdullah M., Haddad, Elias K.
Publicado 2020

Pre-vaccination frequency of circulatory Tfh is associated with robust immune response to TV003 dengue vaccine

por Izmirly, Abdullah M., Pelletier, Adam-Nicolas, Connors, Jennifer, Taramangalam, Bhavani, Alturki, Sawsan O., Gordon, Emma A., Alturki, Sana O., Mell, Joshua C., Swaminathan, Gokul, Karthik, Vivin, Kutzler, Michele A., Kallas, Esper G., Sekaly, Rafick-Pierre, Haddad, Elias K.
Publicado 2022